Ncardia

Leiden, Netherlands · Founded 2010 · Privately Held (backing)

Operator of a biotechnology company intended to provide technologies to expedite drug discovery and development processes. Ncardia is based in Leiden, Netherlands and was founded in 2010. Its last known valuation is $174 million. It has raised $130 million.

Last price · $/share
—
Implied valuation
$174.0M
Total raised
$129.7M
Last round
—
What is Ncardia worth?
$174.0Mlast known valuation
Free account
More of Ncardia with a free account
  • ·The complete investor list: 12 names
  • ·Watch Ncardia: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Ncardia funding history

No rounds on record

No funding rounds for Ncardia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Ncardia valuation

Ncardia's last known valuation is $174 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How Ncardia's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Ncardia, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Ncardia

What is Ncardia worth?
Ncardia's last known valuation is $174.0M.
How much has Ncardia raised?
Ncardia has raised $129.7M in total funding across its recorded rounds.